IFRXInflaRx N.V.
2.100USDMkt Cap: 309.47M $P/E: —3d ago
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator to treat variety of autoimm…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap309.47M $
Enterprise Value139.27M $
Revenue (TTM)-10.10K $
Gross Profit-7.24M $
Net Income (TTM)-45.63M $
Revenue/Share0.0000 USD
Last Price2.100 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees65
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.04
PEG—
EV/EBITDA-3.91
EV/Revenue-13787.31
P/S-29470.73
P/B1.76
EPS (TTM)-0.58
EPS (Forward)-0.40
52W Range
2.02579% of range2.120
52W High2.120 USD
52W Low2.025 USD
Profitability
Gross Margin-24677.94%
Oper. Margin352965.00%
EBITDA Margin0.00%
Profit Margin-155582.08%
ROE-109.81%
ROA-82.65%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-35.31M $
CapEx (TTM)115.69K $
FCF Margin42690.19%
FCF Yield-1.39%
Net Debt-157.68M $
Net Debt/EBITDA4.42
Balance Sheet
Debt/Equity0.02
Current Ratio8.22
Quick Ratio7.95
Book Value/Sh1.148 USD
Cash/Share1.076 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.986 USD
Upside (mean)+280.3%
Target Range3.043 USD – 14.20 USD
$3.043+280.3% to mean$14.20
# Analysts8
Ownership
Shares Out.147.37M
Float105.59M
Insiders2.95%
Institutions64.30%
Short Interest
Short Ratio9.1d
Short % Float6.90%
Short % Out.6.33%
Shares Short9.32M
Short (prev mo.)8.11M
Technical
SMA 501.900 (+10.5%)
SMA 2001.455 (+44.3%)
Beta2.52
S&P 52W Chg21.00%
Avg Vol (30d)419.89K
Avg Vol (10d)1.01M
Technical Indicators
RSI (14)60.0
MACD0.0585
MACD Signal0.0272
MACD Hist.+0.0312
BB Upper2.239 USD
BB Middle1.891 USD
BB Lower1.544 USD
BB Width36.78%
ATR (14)0.1320 USD
Vol Ratio (20d)0.46x